APP and Alzheimer disease: However, these small-molecule tracers do not bind to soluble Aβ aggregates that are assumed to be the toxic species underlying early AD progression [2, 3] or to diffuse Aβ plaques such as those found in AD patients with the Arctic APP mutation [4].